WAM
RKDA icon

Weiss Asset Management’s Arcadia Biosciences RKDA Stock Holding History

Weiss Asset Management’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-63
Closed -$318K – 45
2015
Q2 		$318K Buy
+63
New +$392K 0.38% 27

Other funds holding RKDA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Weiss Asset Management's RKDA Position: Q3 2015 in Review

Weiss Asset Management sold out of Arcadia Biosciences (RKDA) in Q3 2015, closing a stake of 63 shares — an estimated $318K sold.

Weiss Asset Management first reported a position in RKDA in Q2 2015 and held it in 1 quarter. The position peaked at $318K in Q2 2015. 28 funds tracked by Wall St. Rank hold RKDA as of Q3 2015.

  • Weiss Asset Management reported no remaining Arcadia Biosciences position as of Q3 2015 after selling out during the quarter.
  • Weiss Asset Management sold 63 Arcadia Biosciences shares in Q3 2015, an estimated $318K.
  • Weiss Asset Management first reported a position in Arcadia Biosciences in Q2 2015 and held it in 1 quarter.
  • Weiss Asset Management's Arcadia Biosciences position peaked at $318K in Q2 2015.
  • 28 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q3 2015.

Based on Weiss Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.